Luspatercept ameliorates disease phenotype and complications in the Townes mouse model of sickle cell disease
{{output}}
Preclinical data demonstrating that luspatercept mitigates vaso-occlusive and anemia-related complications in the Townes sickle cell model provide a strong rationale for its evaluation in SCD patients. ... ...
